期刊
DALTON TRANSACTIONS
卷 48, 期 40, 页码 15255-15262出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c9dt02381j
关键词
-
资金
- National Natural Science Foundation of China [21867017, 21761033, 21565028]
- Natural Science Foundation of Guangxi [2018GXNSFBA138021, 2018GXNSFBA281188]
- Innovative Team & Outstanding Talent Program of Colleges and Universities in Guangxi [2014-49, 2017-38]
Two novel Pt(II) complexes, [Pt(B-TFA)Cl]Cl (Pt1) and [Pt(J-TFA)Cl]Cl (Pt2) with jatrorrhizine and berberine derivatives (B-TFA and J-TFA) were first prepared as desirable luminescent agents for cellular applications and potent telomerase inhibitors, which can induce bladder T-24 tumor cell apoptosis by targeting telomerase, together with induction of mitochondrial dysfunction, telomere DNA damage and cell-cycle arrest. Importantly, T-24 tumor inhibition rate (TIR) was 50.4% for Pt2, which was higher than that of Pt1 (26.4%) and cisplatin (37.1%). Taken together, all the results indicated that jatrorrhizine and berberine derivatives Pt1 and Pt2 show low toxicity and could be novel Pt-based anti-cancer drug candidates.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据